BioNexus Gene Lab Corp. (BGLC)
2.019
+0.04
(+1.98%)
USD |
NASDAQ |
May 15, 16:00
BioNexus Gene Lab EPS Diluted (Quarterly) : -0.2249 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NPK International, Inc. | 0.1206 |
| Regional Brands, Inc. | -- |
| AmeraMex International, Inc. | 0.0381 |
| Marwynn Holdings, Inc. | -0.0272 |
| AAON, Inc. | 0.4787 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5436M |
| Revenue (Quarterly) | 0.0228M |
| Total Expenses (Quarterly) | 0.5664M |
| Enterprise Value | 1.132M |
| Gross Profit Margin (Quarterly) | -99.56% |
| Profit Margin (Quarterly) | -2.38K% |
| Earnings Yield | -73.57% |
| Normalized Earnings Yield | -72.99 |